Drug composition with controlled drug release rate
    2.
    发明公开
    Drug composition with controlled drug release rate 有权
    Arzneistoffzubereitung mit kontrollierter Wirkstofffreisetzungsrate

    公开(公告)号:EP0913149A1

    公开(公告)日:1999-05-06

    申请号:EP98119415.2

    申请日:1998-10-14

    申请人: SSP Co., Ltd.

    IPC分类号: A61K9/22 A61K9/26 A61K47/36

    摘要: This invention relates to a drug composition with a controlled drug release rate. The drug composition comprises:

    a matrix formed of the following ingredients (a) and (b):

    (a) a biodegradable, biocompatible high-molecular substance and/or polyvalent metal ions or polyvalent metal ion source, and
    (b) hyaluronic acid or a salt thereof; and

    a drug incorporated as an ingredient (c) in said matrix. The drug composition has biodegradability and biocompatibility, permits easy control of a release rate of the drug, and can persistently exhibit its pharmacological effect over a long time.

    摘要翻译: 本发明涉及具有受控药物释放速率的药物组合物。 药物组合物包含:由以下成分(a)和(b)形成的基质:(a)可生物降解的生物相容性高分子物质和/或多价金属离子或多价金属离子源,和(b)透明质酸或 其盐; 以及作为成分(c)掺入所述基质中的药物。 药物组合物具有生物降解性和生物相容性,容易控制药物的释放速度,并且可以长时间持续显示其药理作用。